参考文献/References:
1 KeallP J, Lammering G, LinP S, et al. Tumor control probability predictions forgenetic radiotherapy. Int J Radiat Oncol Biol Phys,2003, 57(1):255-263.
2 De Marco F, Hallez S, Bmlet JM, et al. DNA vaccines against HPV-16 E7-expressing tumour cells. Anticancer Res, 2003, 23(2B):1449-1454.
3 Furumoto H, Irahara M. Human papillomavirus(HPV) and cervical cancer. Med Invest, 2002, 49(3-4):124-133.
4 Rosales C, Valadez-Graham V, Arrellin G, et al. MVA E2 a recombinant vaccinia containing the papilloma virus E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity. Cancer Immunol Immunother, 2000, 49(7):347-360.
5 Garcia-Hernandez E, Gonzalez-Sanchez JL, Andrade-Manzano A, et al. Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine. Cancer Gene Ther, 2006, 13(6):592-597.
6 Green KL, Southgate TD, Mulryan K, et al. Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy. Hum Gene Ther, 2006, 17(2):147-157.
7 Bruning A, Runnebanm IB. CAR is a cell-cell adhesion proteinin human cancer cell sand is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther, 2003, 10(3):198-205.
8 Street SE, Cretney E, Smyth MJ. Perfofin and interferon-γ activities independently control tumor initiation, growth, and metastasis.Blood, 2001, 97(1):192-197.
9 Suk K, Kim YH, Chang I, et al. IFN-alpha sensitizes ME-180 human cervical cancer cells to TNF-alpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation. FEBS Lett, 2001,495(1-2):66.
10 Sethi N, Palefsky J. Treatment of human papillomavirus (HPV) type16-infected cells using herpes simplex virus type 1 thymidine kinase mediated gene therapy trans-criptionally regulated by the HPV E2 protein. Hum Gene Ther, 2003, 14(1):45-57.
11 Bilsland AE, Anderson C J, Fletcher-Monaghan A J, et al. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.Oncogene, 2003, 22(3):370-380.
12 Lim HY, Ahn M, Chung HC. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus. Cancer Gene Ther, 2004, 11(8):532-538.
13 Choo CK, Ling MT, Suen CK, et al. Retrovirus mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells. Gynecol Oncol, 2000, 78(3):293-301.
14 Ho CW, Poo H, Cho YS, et al. HPV E6 antisense induces apoptosis in CaSki cells via suppression of E6 splicing. Exp Mol Med,2002, 34(2):159-166.
15 Lim DS, Bae SM, Kwak SY. Adenovims-mediated p53 treatment enhances photodynamic antitumor response. Hum Gene Ther,2006, 17(3):347-352.
16 Kim JW, Kim TE, Kim YK, et al. Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines. Antisense Nucleic Acid Drug Dev, 1999, 9(6):507-513.
17 Kubota H, Suzuki T, Lu J Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines. Int J Radiat Biol, 2005, 81(9):701-709.
18 Huh JJ, Wolf JK, Fightmaster DL, et al. Transduction of adenovires-mediated wild-type p53 after radiotherapy in human cervireal cancer cells. Gynecol Oncol, 2003, 89(2):243-250.
19 Das S, Somasundaram K. Therapeutic potential of an adenovirus expressing p73beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo. Cancer Biol Ther, 2006, 5(2):210-217.
20 Huh WK, Gomez NJ, Ararat WO, et al. Bax-induced apop-tosis as a novel genetherapy approach for carcinoma of the cervix. Gynecol Oncol, 2001, 83(2):370-377.
21 Ararat WO, Gomez N J, Xiang J, et al. An adenovirus encoding proapoptofic Bax induces apoptosis and enhances the radiation effect in human ovariancancer. Mol Ther, 2000, 1(6):545-554.
相似文献/References:
[1]黄维,李英,龙强,等.中晚期宫颈癌患者调强放疗与同步推量调强放疗预后比较[J].国际放射医学核医学杂志,2016,40(6):429.[doi:10.3760/cma.j.issn.1673-4114.2016.06.006]
Huang Wei,Li Ying,Long Qiang,et al.Clinical effects of IMRT and simultaneous integrated boost-intensity modulated radiation therapy:a comparative study of 277 patients with advanced cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):429.[doi:10.3760/cma.j.issn.1673-4114.2016.06.006]
[2]李玮,谭建.肿瘤基因治疗相关的特异性启动子研究新进展[J].国际放射医学核医学杂志,2014,38(3):185.[doi:10.3760/cma.j.issn.1673-4114.2014.03.011]
Li Wei,Tan Jian.The new progress of the specific promoter for cancer gene therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):185.[doi:10.3760/cma.j.issn.1673-4114.2014.03.011]
[3]王芹,王敬敏,徐畅,等.Ad-Rb94联合照射对体外人大肠癌细胞的抑瘤作用[J].国际放射医学核医学杂志,2014,38(6):351.[doi:10.3760/cma.j.issn.1673-4114.2014.06.001]
Wang Qin,Wang Jing-min,Xu Chang,et al.The effect of Ad-Rb94 combined with radiation on inhibiting the growth of human colorectal cancer cells in vitro[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):351.[doi:10.3760/cma.j.issn.1673-4114.2014.06.001]
[4]王芹,刘晓秋,李进,等.白细胞介素21基因联合不同剂量γ射线照射对乳腺癌细胞生长的影响[J].国际放射医学核医学杂志,2012,36(2):94.[doi:10.3760/cma.j.issn.1673-4114.2012.02.009]
WANG Qin,LIU Xiao-qiu,LI Jin,et al.Effects of interleukin-21 gene combined with different doses of γ-ray radiation on growth of breast carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):94.[doi:10.3760/cma.j.issn.1673-4114.2012.02.009]
[5]石朔,李彪.促血管生成因子在治疗缺血性心脏病中的应用[J].国际放射医学核医学杂志,2013,37(6):355.[doi:10.3760/cma.j.issn.1673-4114.2013.06.008]
SHI Shuo,LI Biao.Utility of the angiogenesis factors in the management of ischemic heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):355.[doi:10.3760/cma.j.issn.1673-4114.2013.06.008]
[6]陈凤华,李进,谭志军,等.Ad-Rb94联合γ射线照射对食管癌细胞生长的影响[J].国际放射医学核医学杂志,2010,34(2):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
CHEN Feng-hua,LI Jin,TAN Zhi-jun,et al.Effects of recombinant adenovirus mediated retinoblastoma gene 94 combined with γ-ray on growth of esophageal carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
[7]郭睿,李彪.钠碘同向转运体基因介导放射性碘治疗肿瘤的研究进展[J].国际放射医学核医学杂志,2010,34(3):147.
GUO Rui,LI Biao.Advances of radioiodine therapy of tumor induced by sodium iodide symporter gene[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):147.
[8]刘道佳,唐明灯,林端瑜,等.18F-FDG SPECT-CT在宫颈癌监测中的价值[J].国际放射医学核医学杂志,2010,34(3):155.
LIU Dao-jia,TANG Ming-deng,LIN Duan-yu,et al.The value of 18F-FDG SPECT-CT in detecting recurrence or metastasis of cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):155.
[9]翟红彦,苏成海.基因治疗联合放射治疗恶性肿瘤的分子机制[J].国际放射医学核医学杂志,2009,33(2):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
ZHAI Hong-yan,SU Cheng-hai.Molecular mechanism of genetherapy combined radiotherapy for malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
[10]方圣伟,奚望,张宏.分子核医学的发展和应用前景[J].国际放射医学核医学杂志,2009,33(6):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]
FANG Sheng-wei,XI Wang,ZHANG Hong.The developments and applications of molecular nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]